European approaches to MDR- GNR prevention and control Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust Blog: www.ReflectionsIPC.comwww.ReflectionsIPC.com.

Slides:



Advertisements
Similar presentations
By Prof. OSSAMA RASSLAN Secretary General, Egyptian Society of Infection Control.
Advertisements

East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
1. 2 Global Travel – who goes? 3 Global Links of NDM to the UK Kumarasamy et al., Lancet Infect Dis :
Development of Healthcare- Associated Infections: Role of the Built Environment James P. Steinberg, MD Division of Infectious Diseases Emory University.
BEST PRACTICES: MRSA PRECAUTIONS Dr. Elizabeth Bryce.
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal
REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
2013 CLOSTRIDIUM DIFFICILE EDUCATIONAL AND CONSENSUS CONFERENCE March 11-12, 2013.
Preventing Healthcare Associated Infections W. Charles Huskins, MD, MSc Associate Professor, Pediatrics Mayo Clinic.
APIC Chapter 13 Journal Club April 15, 2015
Hand Hygiene in Healthcare Connie Cavenaugh, BSN Infection Control UAMS.
MRSA in Corrections Danae Bixler, MD, MPH
Cleaning in the ICU: strong evidence, strong convictions and a dose of reality? Cleaning in the ICU: strong evidence, strong convictions and a dose of.
Physicians: Infection Prevention is in YOUR Hands
Infection Control- Issues in the Community Dr Yimmy Chow Interim Director and Consultant in Communicable Disease Control NW London Health Protection Team,
Topic 9 Minimizing infection through improved infection control.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
A Tiered Approach to Reduce Hospital Onset C. difficile Brian Koll, MD, FACP, FIDSA Medical Director and Chief Infection Prevention and Control, BIMC.
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
Improving Environmental Cleaning and Disinfection in Healthcare Settings Massachusetts Coalition for the Prevention of Medical Errors March 26, 2008 A.
RESULTS INTRODUCTION METHODS CONCLUSION  Extended spectrum beta-lactamases producing Enterobacteriacae (ESBLPE) have become a major cause of hospital-acquired.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
Time To Regain Control Management of Multi-Drug Resistant Organisms in Healthcare Settings
Carbapenemase- Producing Carbapenem-Resistant Enterobacteriaceae Nicole Hearon, HAI Epidemiologist Surveillance and Investigation Division Indiana State.
Carbapenem-resistant Enterobacteriacea (ent-ə-rō-ˌbak-ˌtir-ē-ˈā-sē-ˌā) July 2013
How Hands Transmit Infection. How do our hands transmit infection? ■Hands are the most common vehicle to transmit health care-associated pathogens (e.g.,
Rising to the challenge of multidrug-resistant Gram-negative bacteria
Detecting CPE: time to throw away those agar plates?
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
European Centre for Disease Prevention and Control
30mm 10mm logo safe area 10mm logo safe area EDITING NOTES All copy must stay within the content limit guidelines. Any image added to a slide with text.
Containing CRE spread Jon Otter, PhD FRCPath Scientific Director, Healthcare, Bioquell Research Fellow, King’s College London
30mm 10mm logo safe area 10mm logo safe area EDITING NOTES All copy must stay within the content limit guidelines. Any image added to a slide with text.
MRSA: To isolate or not to isolate? Jean-François TIMSIT, MD PhD Medical ICU, University hospital Grenoble, France INSERM U 578 ESICM Barcelona – Sept.
CRE/CPE/CRO: Demystifying the microbiology and opportunities for whole genome sequencing Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
CPE, CRE, CPO and CRABs! Jon Otter, PhD FRCPath Imperial College Hospitals NHS Trust Blog:
Tackling antimicrobial resistance – what is the current situation in Europe? Dr Andrea Ammon, ECDC Director, 27 June 2017, European Parliament.
Additional Precautions
The growing dangers around CPE
Jon Otter, PhD FRCPath Imperial College London @jonotter Blog:
Jon Otter, PhD FRCPath Imperial College London @jonotter Blog:
Screening for CPE: sensitivity of serial admission screens
CPE screening: seek and ye shall find!
Rising to the challenge of multidrug-resistant Gram-negative bacteria
Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford,
IPC – new, novel, and exciting
GNBSI Can we really halve GNBSIs? Jon Otter, PhD FRCPath
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Counting the cost of controlling an outbreak of CPE: an economic evaluation Jonathan A. Otter,1,2 Philip Burgess,3 Frances Davies,2 Siddharth Mookerjee,2.
Nine decades of antibiotics: how many years of antibiotic resistance?
The ‘bed location lottery’: the MDRO status of the prior bed occupant affects the risk of acquisition Jon Otter, PhD Scientific Director, Healthcare, Bioquell.
Using the Toolkit to build a CPE policy
Main modes of transmission CPE
Coping with multiresistant bacteria in the ICU
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Counting the cost and value of hospital cleaning and disinfection
Carbapenem-resistant Gram-negative bacteria
From hospital microbiome to new answers for environmental cleaning
Cost utility of alternative Carbapenemase
The role of environmental surfaces in disease transmission
AMR: a clinical perspective
CPE: coming to a hospital near you!
Detecting and managing CPE outbreaks: seek and you shall find
Hospital cleaning and disinfection: we can do better!
Removal of sinks from ICU Patient rooms
The management of CPE outbreaks panel
Implementing innovation when financial times are hard
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Presentation transcript:

European approaches to MDR- GNR prevention and control Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust Blog:

THE END OF ANTIBIOTICS IS NIGH

“CRE are nightmare bacteria.” Dr Tom Frieden, CDC Director “If we don't take action, then we may all be back in an almost 19th Century environment where infections kill us as a result of routine operations.” Dame Sally Davies, Chief Medical Officer “If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine where treatable infections and injuries will kill once again.” David Cameron, Prime Minister, UK “The rise of antibiotic-resistant bacteria, however, represents a serious threat to public health and the economy.” Barack Obama, President USA What’s the problem?

CRE in the UK and US

Universal or targeted approach?

Evidence-free zone

Guidelines = Policy

Acronym minefield MDR-GNR MDR-GNB CRO CRE CPE CPC CRC CRAB ESBL KPC

Care environment Hand hygiene PPE Asepsis: optimal use of invasive devices; PVC, CVC, UC Safe Injection practices Safe lumbar Puncture practices Resuscitation safety Patient placement Resp hygiene Linens Care equipment BBF spillage BBF exposure prevention & management Health Protection Scotland: Centres for Disease Control: UK Epic3: WHO: Safe use and disposal of sharps Risk assessment Waste disposal

MDR- GNR Toolbox Hand hygiene Cleaning / disinfection HCW screening Decol. Cohorting staff / patients Note flaggingEducation Env. screening Contact precautions Active screening Antibiotic stewardship Tacconelli et al. Clin Microbiol Infect 2014;20 Suppl 1:1-55.

MDR- GNR Toolbox Hand hygiene Cleaning / disinfection HCW screening Decol. Cohorting staff / patients Note flaggingEducation Env. screening Contact precautions Active screening Antibiotic stewardship Tacconelli et al. Clin Microbiol Infect 2014;20 Suppl 1:1-55.

Who do I screen? UK PHE CPE Toolkit UK PHE CPE Toolkit screening triggers: a) an inpatient in a hospital abroad, or b) an inpatient in a UK hospital which has problems with spread of CPE (if known), or c) a‘previously’positive case. Also consider screening admissions to high- risk units such as ICU, and patients who live overseas.

How do I screen?  Rectal swab is the best sample –Insert no more than 2cm into rectum –Twist gently and withdraw –Ideally want to see faeces on swab.  Patient and staff education as to why this is needed in order to overcome taboos  Alternate specimen is stool sample, but have to wait for the patient to ‘go’

Does screening and isolation work? All MDROsMRSAVREESBLs Baseline trend– ↑ –– Hygiene intervention step-change –––– Hygiene intervention trend change ↓↓ –– Screening step-change–––– Screening trend change – ↑ –– Rapid vs. conventional step-change ↑ –– ↑ Rapid vs. conventional trend-change –––– Derde et al. Lancet Infect Dis 2014;14:31-39Derde et al. Lancet Infect Dis 2014;14:31-39.

MDR- GNR Toolbox Hand hygiene Cleaning / disinfection HCW screening Decol. Cohorting staff / patients Note flaggingEducation Env. screening Contact precautions Active screening Antibiotic stewardship Tacconelli et al. Clin Microbiol Infect 2014;20 Suppl 1:1-55.

40% Median hand hygiene compliance from 95 studies. Erasmus et al. Infect Control Hosp Epidemiol 2010;31: Hand hygiene

MDR- GNR Toolbox Hand hygiene Cleaning / disinfection HCW screening Decol. Cohorting staff / patients Note flaggingEducation Env. screening Contact precautions Active screening Antibiotic stewardship Tacconelli et al. Clin Microbiol Infect 2014;20 Suppl 1:1-55.

Otter & French. J Clin Microbiol 2009;47: Surface survival

Surface survival – strain variation Otter & French. J Clin Microbiol 2009;47:

Conclusion  K. pneumoniae seems to be more environmental than E. coli. 1,2  Surface contamination on five standardized sites surrounding patients with ESBL- producing Klebsiella spp. (n=48) or ESBL-producing E. coli (n=46). 1 K. pneumoniae vs. E. coli 1.Guet-Revillet et al. Am J Infect Control 2012;40: Gbaguidi-Haore. Am J Infect Cont 2013;41: Freeman et al. Antimicrob Resist Infect Control 2014;3:5. P<0.001 Risk factors for ESBL-E contamination = ESBL- KP, urinary catheter; carbapenem therapy was protective. 3

Persistent contamination Manian et al. Infect Control Hosp Epidemiol 2011;32:  140 samples from 9 rooms after 2xbleach  5705 samples from 312 rooms after 4xbleach  2680 sites from 134 rooms after HP vapor 26.6% of rooms remained contaminated with either MRSA or A. baumannii following 4 rounds of bleach disinfection HP vapor decon

Enterobacteriaceae “less environmental” Nseir et al. Clin Microbiol Infect 2011;17: Ajao et al. Infect Control Hosp Epidemiol 2013;34:

MDR-GNR cleaning & disinfection checklist  Clean / declutter  Monitor cleaning process (e.g. fluorescent markers)  Enhanced daily disinfection using bleach  All equipment disinfected before leaving room  Terminal disinfection using bleach or, ideally, H 2 O 2 vapor Gopinath et al. Infect Control Hosp Epidemiol 2013;34: Snitkin et al. Sci Transl Med 2012;4:148ra Verma et al. J Infect Prevent 2013;7:S37.

MDR- GNR Toolbox Hand hygiene Cleaning / disinfection HCW screening Decol. Cohorting staff / patients Note flaggingEducation Env. screening Contact precautions Active screening Antibiotic stewardship Tacconelli et al. Clin Microbiol Infect 2014;20 Suppl 1:1-55.

Carbapenem use, Europe ECDC point prevalence survey 2013ECDC point prevalence survey 2013.

Hou et al. PLoS ONE 2014;9:e101447; * = significant difference before vs. after. Antimicrobial stewardship – impact Evaluating impact of 6 month antimicrobial stewardship intervention on an ICU by comparing bacterial resistance for matched 6 month periods either side of intervention. * * * * * *

MDR- GNR Toolbox Hand hygiene Cleaning / disinfection HCW screening Decol. Cohorting staff / patients Note flaggingEducation Env. screening Contact precautions Active screening Antibiotic stewardship Tacconelli et al. Clin Microbiol Infect 2014;20 Suppl 1:1-55.

Deisolation? 1.Bird et al. J Hosp Infect 1998;40: Pacio et al. Infect Control Hosp Epidemiol 2003;24: Zahar et al. J Hosp Infect 2010;75: O'Fallon et al. Clin Infect Dis 2009;48: Zimmerman et al. Am J Infect Control 2013;41: AuthorYearSetting N pts Organism Duration of colonization Bird Elderly care facilities, Scotland 38ESBL K. pneumoniae Mean 160 days (range 7-548) Pacio Long term care facility, USA 8 Resistant Gram- negative rods Median 77 days (range ) Zahar Paediatric hospital, France 62 ESBL Enterobacteriaceae Median 132 days (range ) O'Fallon Long term care facility, USA 33 Resistant Gram- negative rods Median 144 days (range 41–349) Zimmerman Patients discharged from hospital, Israel 97CREMean 387 days

Saidel-Odes et al. Infect Control Hosp Epidemiol 2012;33: CRE colonized patients in each arm given gentamicin + polymyxin (SDD arm) or placebo (Control arm) ‘Selective’ digestive decontamination

Decolonisation using faecal microbiota transplantation (FMT)  82 year old colonised with CRE.  Carriage was delaying her admission to a nursing home.  Single dose of FMT decolonised her at 7 and 14 days. Laiger et al. J Hosp Infect 2015 in press. Buffie & Pamer. Nat Rev Microbiol 2013;13:

Chlorhexidine – efficacy Lin et al. Infect Control Hosp Epidemiol 2014; 35: Impact of chlorhexidine gluconate (CHG) daily bathing on skin colonization with KPC-producing K. pneumoniae in 64 long-term acute care patients.

Chlorhexidine – reduced susceptibility Suwantarat et al. Infect Control Hosp Epidemiol 2014;35: Proportion of BSI isolates with reduced susceptibility to chlorhexidine on units using chlorhexidine gluconate (CHG) daily bathing (n=28) or not (n=94). 33% (p=0.028)

Which do you consider to be the most important measure to prevent transmission? Data from around 150 webinar participants, mainly in the US, 2014.

Cataldo et al. ECCMID Typen studiesFailure rateOdds ratio Bundled intervention7528% 1.9 Single intervention1145%

What works? NIH Palmore. Clin Infect Dis 2013;57: Also:  Daily chlorhexidine baths  ‘Enforcers’ for hand hygiene compliance  Communication with all staff  Hydrogen peroxide vapor  Characterisation of outbreak strains (WGS)

What works? Israel Schwaber et al. Clin Infect Dis 2011;52: * Physical segregation of CRE carriers; cohorted staff; appointed taskforce. *

Summary 1.Enterobacteriaceae (mainly K. pneumoniae) and non-fermenters (mainly A. baumannii) have fundamental differences in their epidemiology – and require a different approach to control. 2.We still don’t really know what works to control MDR-GNR. 3.A “kitchen sink” approach (aka bundle) should be deployed! 4.Effective strategies should include:  Hand hygiene  Screening & contact precautions  Antimicrobial stewardship  Cleaning & disinfection

European approaches to MDR- GNR prevention and control Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust Blog: